Global and China Osteoarthritis Drugs Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint, including analgesics, nonsteroidal anti-inflammatory drugs, corticosteroids, hyaluronic acid, and phase III drugs.

    This report elaborates on the current development of the Osteoarthritis Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • GlaxoSmithKline

    • Abbott

    • Eli Lilly

    • Flexion Therapeutics

    • Sanofi

    • Pfizer

    • Johnson & Johnson

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral

    • Injection

    • External

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Osteoarthritis Drugs Industry Overview

      • 1.1.1 Osteoarthritis Drugs Market Scope and Market Segments

      • 1.1.2 Osteoarthritis Drugs Industry Characteristics

      • 1.1.3 Global and China Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Osteoarthritis Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Osteoarthritis Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral

      • 1.2.2 Injection

      • 1.2.3 External

    • 1.3 Global Osteoarthritis Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Osteoarthritis Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Osteoarthritis Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Osteoarthritis Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Osteoarthritis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Osteoarthritis Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Osteoarthritis Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Osteoarthritis Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Osteoarthritis Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Osteoarthritis Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Osteoarthritis Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Osteoarthritis Drugs Industry PEST Analysis

    • 2.3 Osteoarthritis Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Osteoarthritis Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Osteoarthritis Drugs Industry

    Chapter 3 Global and China Osteoarthritis Drugs Market, by Manufacturer

    • 3.1 Global and China Osteoarthritis Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Osteoarthritis Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Osteoarthritis Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Osteoarthritis Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Osteoarthritis Drugs Market Top 3 Players

    Chapter 4 Global and China Osteoarthritis Drugs Market, by Type (2017-2028)

    • 4.1 Osteoarthritis Drugs Market Trend, by Type

    • 4.2 Global Osteoarthritis Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Osteoarthritis Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Osteoarthritis Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Osteoarthritis Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Osteoarthritis Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Osteoarthritis Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Osteoarthritis Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Osteoarthritis Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Osteoarthritis Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Osteoarthritis Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Osteoarthritis Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Osteoarthritis Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Osteoarthritis Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Osteoarthritis Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Osteoarthritis Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Osteoarthritis Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Osteoarthritis Drugs Market Analysis

    • 7.1 North America Osteoarthritis Drugs Market, by Type

    • 7.2 North America Osteoarthritis Drugs Market, by Application

    • 7.3 North America Osteoarthritis Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Osteoarthritis Drugs Market Analysis

    • 8.1 Europe Osteoarthritis Drugs Market, by Type

    • 8.2 Europe Osteoarthritis Drugs Market, by Application

    • 8.3 Europe Osteoarthritis Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Osteoarthritis Drugs Market Analysis

    • 9.1 APAC Osteoarthritis Drugs Market, by Type

    • 9.2 APAC Osteoarthritis Drugs Market, by Application

    • 9.3 APAC Osteoarthritis Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Osteoarthritis Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Osteoarthritis Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Osteoarthritis Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Osteoarthritis Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Osteoarthritis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Osteoarthritis Drugs Company Profiles

      • 11.1 GlaxoSmithKline

        • 11.1.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 GlaxoSmithKline Osteoarthritis Drugs Product Profiles, Application and Specification

        • 11.1.3 GlaxoSmithKline Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Abbott

        • 11.2.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Abbott Osteoarthritis Drugs Product Profiles, Application and Specification

        • 11.2.3 Abbott Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Eli Lilly

        • 11.3.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Eli Lilly Osteoarthritis Drugs Product Profiles, Application and Specification

        • 11.3.3 Eli Lilly Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Flexion Therapeutics

        • 11.4.1 Flexion Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Flexion Therapeutics Osteoarthritis Drugs Product Profiles, Application and Specification

        • 11.4.3 Flexion Therapeutics Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Sanofi

        • 11.5.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Sanofi Osteoarthritis Drugs Product Profiles, Application and Specification

        • 11.5.3 Sanofi Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pfizer

        • 11.6.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pfizer Osteoarthritis Drugs Product Profiles, Application and Specification

        • 11.6.3 Pfizer Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Johnson & Johnson

        • 11.7.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Johnson & Johnson Osteoarthritis Drugs Product Profiles, Application and Specification

        • 11.7.3 Johnson & Johnson Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Osteoarthritis Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Osteoarthritis Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Osteoarthritis Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Osteoarthritis Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Osteoarthritis Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Osteoarthritis Drugs Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Osteoarthritis Drugs Market Size and Growth Rate of Injection (2017-2028)

    • Figure Global Osteoarthritis Drugs Market Size and Growth Rate of External (2017-2028)

    • Figure Global Osteoarthritis Drugs Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Osteoarthritis Drugs Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global Osteoarthritis Drugs Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America Osteoarthritis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Osteoarthritis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Osteoarthritis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Osteoarthritis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Osteoarthritis Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Osteoarthritis Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Osteoarthritis Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Osteoarthritis Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Osteoarthritis Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Osteoarthritis Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Osteoarthritis Drugs Market Share, by Manufacturer in 2022

    • Table Global Osteoarthritis Drugs Sales Volume, by Type (2017-2028)

    • Table Global Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Osteoarthritis Drugs Sales Value, by Type (2017-2028)

    • Table Global Osteoarthritis Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Osteoarthritis Drugs Price Trend, by Type (2017-2028)

    • Table China Osteoarthritis Drugs Sales Volume, by Type (2017-2028)

    • Table China Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Osteoarthritis Drugs Sales Value, by Type (2017-2028)

    • Table China Osteoarthritis Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Osteoarthritis Drugs Price Trend, by Type (2017-2028)

    • Table Global Osteoarthritis Drugs Sales Volume, by Application (2017-2028)

    • Table Global Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Osteoarthritis Drugs Sales Value, by Application (2017-2028)

    • Table Global Osteoarthritis Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Osteoarthritis Drugs Sales Value Share, by Application (2017-2028)

    • Table China Osteoarthritis Drugs Sales Volume, by Application (2017-2028)

    • Table China Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Osteoarthritis Drugs Sales Value, by Application (2017-2028)

    • Table China Osteoarthritis Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Osteoarthritis Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Osteoarthritis Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Osteoarthritis Drugs Sales Volume, by Type (2017-2028)

    • Table North America Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Osteoarthritis Drugs Sales Volume, by Application (2017-2028)

    • Table North America Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Osteoarthritis Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Osteoarthritis Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Osteoarthritis Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Osteoarthritis Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Osteoarthritis Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Osteoarthritis Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Osteoarthritis Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Osteoarthritis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Osteoarthritis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Osteoarthritis Drugs Sales Value and Growth Rate (2017-2028)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Product Profiles, Application and Specification

    • Table Abbott Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Flexion Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Flexion Therapeutics Product Profiles, Application and Specification

    • Table Flexion Therapeutics Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Osteoarthritis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.